Navigation Links
'It's Still Too Early to Be Popping Champagne Corks' - Expert to Comment on Health Care Reform- House Healthcare Proposal
Date:7/29/2009

WASHINGTON, July 29 /PRNewswire-USNewswire/ -- As you continue to cover the House healthcare proposal Dr. Leighton Ku, health policy researcher and professor is available to speak with you about this subject. Below is a statement about the new House Healthcare Compromise from Dr. Leighton Ku, professor in the Department of Health Policy at George Washington University Medical Center.

"The news that conservative Democrats in the House, also known as the Blue Dogs, have reached a basic agreement on the House health reform bill is very good news, because it suggests that the House of Representatives will have a framework that could enable it to pass a health reform bill in the near future. Similar news that the Senate Finance Committee is moving closer to agreement on a bipartisan bill also suggests that the Senate will also be able to move forward. Of course, many groups still desperately want to block health reform, so it is still too early to be popping champagne corks."

About Leighton Ku, PhD, MPH

Professor of Health Policy

The George Washington University

As a health policy researcher, a public policy analyst, and an advocate, Dr. Ku's career has been built around the effort to understand and improve access to affordable health care for vulnerable populations. Among his areas of expertise are Medicaid, the State Children's Health Insurance Program (SCHIP), immigrant health, state health reform, and health care financing and budgets, with an emphasis on strengthening the health care safety net. "I am interested in applying the lessons of research to policies and programs at the federal and state levels, and working with governmental officials, community groups and advocacy organizations to do it," he says.

Professor Ku joined SPHHS as a full-time faculty member in 2008, but he has held adjunct positions at GW's School of Public Policy and Public Administration since the early 1990s. During that time, he also served as a senior fellow at the Washington-based Center on Budget and Policy Priorities, which focuses on improving policies for low- and moderate-income Americans; as principal researcher at the Urban Institute; and as a policy and budget analyst for the federal Women, Infants and Children (WIC) nutrition program.

Education

Bachelor of Arts (Biochemistry), Harvard College, 1975

Master of Science (Nutritional sciences), University of California, Berkeley, 1979

Master of Public Health, University of California, Berkeley, 1979

Doctor of Philosophy (Health policy), Boston University, 1990

Research

Professor Ku is the author, or co-author, of more than 200 articles and reports about health policy and public health focused on health care access and insurance coverage for low-income and vulnerable populations.

Community Service

Dr. Ku has testified before Congress and state legislatures and has submitted expert affidavits in federal and state lawsuits involving Medicaid cost-sharing and immigrant rights. He serves on the National Advisory Board of the Center on Social Disparities on Health at the University of California at San Francisco and on the board of the Alliance for Fairness in Reforms to Medicaid. In 2005, he earned an award from the Mississippi Center for Justice for promoting racial and economic justice.


'/>"/>
SOURCE George Washington University
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference
2. Boston Scientific Announces Election of Katharine Bartlett and Bruce Byrnes to Its Board of Directors
3. Humanitas Designated as Approved Provider by California Board of Registered Nursing for Continuing Education Course Credit and Units
4. Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production
5. Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday, August 5, 2009
6. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
7. OrthoDynamix LLC Launches ArthroSteer(TM): Reaching New Limits in Arthroscopy
8. Mylan Reiterates and Stands Behind Its 48-Year Commitment and Track Record of Quality
9. West Los Angeles Dental Practice Adds ezlase Laser Treatment to its Services
10. Stress, Bad Bedtime Habits Cause Insomnia
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology: